Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study
- Resource Type
- Article
- Authors
- Bontzos, Georgios; Bagheri, Saghar; Ioanidi, Larissa; Kim, Ivana; Datseris, Ioannis; Gragoudas, Evangelos; Kabanarou, Stamatina; Miller, Joan; Tsilimbaris, Miltiadis; Vavvas, Demetrios G.
- Source
- Ophthalmology Retina; December 2020, Vol. 4 Issue: 12 p1138-1145, 8p
- Subject
- Language
- ISSN
- 24687219; 24686530
To investigate the inter-individual variability in duration of anti-vascular endothelial growth factor (VEGF) treatment effect in neovascular age-related macular degeneration (nvAMD).